itmn

InterMune Soaring 90% in Early Pre-Market on European Commit

agency, chmp, commission, committee, disease, drug, ema, esbriet, eu, european, fibrosis, human, idiopathic, intermune, ipf, itmn, lung, markets, medicinal, medicines, mild, products, pulmonary, treatment, use

InterMune (ITMN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for Esbriet (pi

By FNN Staff
root@fnn-online.com

Latest News from FNNO

Shares of United Community Banks Rise to...

United Community Banks (NASDAQ:UCBI) traded today at a new 52-week high of $21.65. App ...

Shares of Telecom Argentina Fall Below P...

Shares of Telecom Argentina (NYSE:TEO) traded today at $17.74, breaking its 52-week low ...

Shares of Thompson Creek Metals Have Fal...

Thompson Creek Metals (NYSE:TC) traded today at a new 52-week low of $0.74. This new l ...

Shares of Stratasys Fall to a New 52-Wee...

Stratasys (NASDAQ:SSYS) traded today at a new 52-week low of $33.68. Approximately 576 ...

Snap-On: 52-Week High Recently Eclipsed ...

Snap-On (NYSE:SNA) traded today at a new 52-week high of $162.29. Approximately 204,00 ...

Recent 52-Week Low Surpassed in Shares o...

Stein Mart (NASDAQ:SMRT) traded today at a new 52-week low of $10.40. Approximately 68 ...

Solera Holdings: The Losing Streak Conti...

Solera Holdings (NYSE:SLH) traded at a new 52-week low today of $43.99. Approximately ...

Shares of Skechers U.S.A. Rise Above Pre...

Skechers U.S.A. (NYSE:SKX) traded today at a new 52-week high of $116.54. So far today ...

Most Popular Video News